Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Real-World Evidence: US FDA Framework Emphasizes Data Fitness And Study Quality

Executive Summary

Agency’s approach to assessing real-world evidence for effectiveness will be guided by three key principles: fitness for use of the underlying data, adequacy of the study design, and satisfactory monitoring and data collection.


Related Content

Real-World Evidence Takes Courage: A Conversation With IQVIA’s Nancy Dreyer
FDA's Real World Study On Adoption Of PD-1 Dosing Change Aims To Inform Reviewers
Takeda's Investments In Data Science Seek Improved Trial Outcomes, R&D Efficiency
External Control Arms: Better Than Single-Arm Studies But No Replacement For Randomization
US FDA Is Hesitant About Using Observational Studies In Real-World Evidence Framework
Digital Transformation Of Clinical Trials Is Shared Responsibility, CRO Industry Says
Gottlieb Takes Aim At CROs’ ‘Outdated Processes’ In Push For Clinical Trial Digitization
Real-World Evidence Demo Projects From US FDA To Include New Mobile App
Real-World Evidence: US FDA’s Prucalopride Review Shows Datasets' Utility And Limitations
Real-World Data: Precertification Could Aid Use For Regulatory Decisions


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts